Page last updated: 2024-12-08

angiotensin ii, sar(1)-val(5)-

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

angiotensin II, Sar(1)-Val(5)-: RN given refers to L-Val [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID171011
CHEMBL ID3250938
MeSH IDM0121791

Synonyms (9)

Synonym
angiotensin ii, sar(1)-val(5)-
angiotensin ii, sarcosyl(1)-valine(5)-
51274-62-5
angiotensin ii, 1-(n-methylglycine)-5-l-valine-
1-sar-5-val-angiotensin
CHEMBL3250938
DTXSID80199269
sar-arg-val-tyr-val-his-pro-phe
PD133155
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID1146286Intrinsic activity at rabbit angiotensin AT2 receptor in aorta strips under exclusion of long wavelength UV light1978Journal of medicinal chemistry, Sep, Volume: 21, Issue:9
Photoaffinity labeling of the angiotensin II receptor. 1. Synthesis and biological activities of the labeling peptides.
AID1135922Inactivation of angiotensin 2 receptor in albino New Zealand rabbit aorta assessed as relaxation of angiotensin-induced contraction at 0.2 uM treated for 180 mins followed by UV light exposed for 10 mins relative to control in presence of [Leu8]-AT1979Journal of medicinal chemistry, Sep, Volume: 22, Issue:9
Photoaffinity labeling of the angiotensin II receptor. 3. Receptor inactivation with photolabile hormone analogues.
AID1135915Agonist activity at angiotensin 2 receptor in albino New Zealand rabbit aorta in absence of UV light1979Journal of medicinal chemistry, Sep, Volume: 22, Issue:9
Photoaffinity labeling of the angiotensin II receptor. 3. Receptor inactivation with photolabile hormone analogues.
AID1135914Intrinsic activity at angiotensin 2 receptor in albino New Zealand rabbit aorta in absence of UV light1979Journal of medicinal chemistry, Sep, Volume: 22, Issue:9
Photoaffinity labeling of the angiotensin II receptor. 3. Receptor inactivation with photolabile hormone analogues.
AID1135918Inactivation of angiotensin 2 receptor in albino New Zealand rabbit aorta assessed as relaxation of angiotensin-induced contraction at 0.2 uM treated for 180 mins followed by UV light exposed for 10 mins relative to control in presence of noradrenaline1979Journal of medicinal chemistry, Sep, Volume: 22, Issue:9
Photoaffinity labeling of the angiotensin II receptor. 3. Receptor inactivation with photolabile hormone analogues.
AID1146285Agonist activity at rabbit angiotensin AT2 receptor in aorta strips assessed as peptide concentration required to produce 50% maximal response under exclusion of long wavelength UV light1978Journal of medicinal chemistry, Sep, Volume: 21, Issue:9
Photoaffinity labeling of the angiotensin II receptor. 1. Synthesis and biological activities of the labeling peptides.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (66.67)18.7374
1990's2 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.41 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]